Skip to content
Home » Medications » Calcium acetate-  667 mg, 100 stk.

Calcium acetate-  667 mg, 100 stk.

Calcium-based phosphate binder for CKD

Description

Generic Name: Calcium Acetate
Brand Name: PhosLo, Eliphos
Drug Class: Phosphate Binder (calcium-based)


This is a prescription medicine, which requires a valid prescription!

Indications

  • Hyperphosphatemia in Chronic Kidney Disease (CKD):
  • Used to control high blood phosphate levels in patients with end-stage renal disease (ESRD) on dialysis. Helps prevent bone disorders and vascular calcification caused by phosphate retention.
Mechanism of Action

Calcium acetate:

  • Binds to dietary phosphate in the gastrointestinal tract.
  • Forms insoluble calcium phosphate complexes that are excreted in feces.
  • Reduces phosphate absorption and lowers serum phosphate levels.
Dosage and Administration
  • Form: Oral capsules or tablets, 667 mg per unit (equivalent to ~169 mg elemental calcium)
  • Typical Starting Dose: 2 capsules/tablets with each meal (total of ~6/day)
  • Titration: Adjust based on serum phosphate levels; monitor regularly
  • Maximum Dose: Determined by calcium and phosphate control
  • Must be taken with meals to be effective
Side Effects
  • Common:
    • Hypercalcemia (especially when combined with other calcium sources or vitamin D)
    • Constipation
    • Nausea, vomiting
    • Loss of appetite
  • Serious (Rare):
    • Vascular or soft tissue calcification
    • Confusion or mental changes (in case of severe hypercalcemia)
    • Arrhythmias
Contraindications
  • Hypercalcemia
  • Severe hyperparathyroidism not adequately controlled
  • Hypersensitivity to calcium acetate or its excipients

Information

Warnings and Precautions

  • Monitor serum calcium and phosphate regularly
  • Use with caution in patients prone to hypercalcemia (e.g., those on vitamin D therapy)
  • Avoid concurrent high-calcium diets or supplements unless advised
  • May contribute to calciphylaxis in susceptible individuals

Drug Interactions

  • May interfere with absorption of:
    – Tetracycline antibiotics
    – Fluoroquinolones
    – Levothyroxine
    (Separate administration by at least 2 hours)

Pregnancy & Lactation

  • Pregnancy: Generally considered safe at normal doses; use under medical supervision
  • Lactation: Small amounts may pass into breast milk; considered compatible

Request Now

Please enable JavaScript in your browser to complete this form.
Terms & Conditions

Direct Enquiries
For any inquiries, please feel free to contact us directly via email at the link below.
pharmacy@doctorworld.eu

DISCLAIMER

PLEASE AVOID SELF-DIAGNOSIS AND SELF-MEDICATION!

Our website content is posted for informational purposes only. It is not intended to be used for primary diagnoses-making and should not replace a consultation with a professional health care provider. If you have any health issues or complaints, please consult your primary physician.

Health care data provided for informational purposes is not an alternative to an in-person physician consultation.